Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis.


Journal

American journal of clinical pathology
ISSN: 1943-7722
Titre abrégé: Am J Clin Pathol
Pays: England
ID NLM: 0370470

Informations de publication

Date de publication:
08 Nov 2021
Historique:
pubmed: 13 5 2021
medline: 13 1 2022
entrez: 12 5 2021
Statut: ppublish

Résumé

Numerous studies on malignant mesothelioma (MM) highlight the prognostic importance of histologic subtype, nuclear grade, and necrosis. This study compares these parameters in paired biopsy and resection specimens of pleural MM. Histologic subtype, percentage of epithelioid morphology, nuclear grade, and the presence or absence of necrosis were compared in 429 paired biopsies and resection specimens of pleural MM from 19 institutions. Histologic subtype was concordant in 81% of cases (κ = 0.58). When compared with resection specimens, epithelioid morphology at biopsy had a positive predictive value (PPV) of 78.9% and a negative predictive value (NPV) of 93.5%; sarcomatoid morphology showed high PPV (92.9%) and NPV (99.3%), and biphasic morphology PPV was 89.7% and NPV was 79.7%. Agreement of the percentage of epithelioid morphology was fair (κ = 0.27). Nuclear grade and necrosis were concordant in 75% (κ = 0.59) and 81% (κ = 0.53) of cases, respectively. Nuclear grade showed moderate (κ = 0.53) and substantial (κ = 0.67) agreement from patients with and without neoadjuvant therapy, respectively, and necrosis showed moderate (κ = 0.47 and κ = 0.60) agreement, respectively, in the same subsets of paired specimens. Paired biopsy-resection specimens from pleural MM show overall moderate agreement in pathologic parameters. These findings may help guide postbiopsy management and triage of patients with MM.

Identifiants

pubmed: 33978147
pii: 6274463
doi: 10.1093/ajcp/aqab054
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

989-999

Informations de copyright

© American Society for Clinical Pathology, 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Jefree J Schulte (JJ)

Department of Pathology, University of Chicago, Chicago, IL, USA.
Department of Pathology and Lab Medicine, University of Wisconsin, Madison, WI, USA.

David B Chapel (DB)

Department of Pathology, University of Chicago, Chicago, IL, USA.
Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

Richard Attanoos (R)

Department of Cellular Pathology, University Hospital of Wales and School of Medicine, Cardiff University, Cardiff, UK.

Luka Brcic (L)

Diagnostics and Research Institute of Pathology, Medical University of Graz, Graz, Austria.

Juliet Burn (J)

Douglass Hanly Moir Pathology, Sydney, Australia.

Kelly J Butnor (KJ)

Department of Pathology, University of Vermont Medical Center, Burlington, VT, USA.

Nina Chang (N)

Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Canada.

Heather Chen (H)

Department of Pathology, University of Chicago, Chicago, IL, USA.

Sanja Dacic (S)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Marc De Perrot (M)

Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Canada.

Junya Fukuoka (J)

Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Francoise Galateau-Salle (F)

Department of Pathology, MESOPATH-MESOBANK, Centre León Bérard, Lyon, France.

Theresa Godschachner (T)

Diagnostics and Research Institute of Pathology, Medical University of Graz, Graz, Austria.

Kenzo Hiroshima (K)

Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan.

Sonja Klebe (S)

Department of Anatomical Pathology, SA Pathology, Flinders University, Adelaide, Australia.

Thomas Krausz (T)

Department of Pathology, University of Chicago, Chicago, IL, USA.

Leslie Litzky (L)

Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

Alberto M Marchevsky (AM)

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Jeffrey Mueller (J)

Department of Pathology, University of Chicago, Chicago, IL, USA.

Kazuki Nabeshima (K)

Department of Pathology, Fukuoka University Hospital, Fukuoka, Japan.

Andrew G Nicholson (AG)

Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, UK.

Prodipto Pal (P)

Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Canada.

Anja C Roden (AC)

Department of Laboratory Medicine and Pathology; Mayo Clinic, Rochester, MN, USA.

Sara Rorvig (S)

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Eric Santoni-Rugiu (E)

Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Henry Tazelaar (H)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.

Ming-Sound Tsao (MS)

Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Canada.

Ann E Walts (AE)

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Birgit Weynand (B)

Department of Pathology, Universitair Ziekenhuis Leuven, Leuven, Belgium.

Yoshiaki Zaizen (Y)

Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Yu Zhi Zhang (YZ)

Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, UK.

Aliya N Husain (AN)

Department of Pathology, University of Chicago, Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH